Priority Date: 16.08.12 (US 201261684066P)

CANCER DIAGNOSTICS USING BIOMARKERS

  • Application ID: EP13829137
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 1906
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination C12, C40, and G01 is specialized in the combination C12, C40, and G01. There is no patent agent firm in the market, which is specialized in this combination of IPC classes.

Timeline

  • 16.08.2012 - Priority Date (US 201261684066P)
  • 20.02.2014 - Publication A2 (WO2014028884)
  • 24.06.2015 - Publication A2 (EP2885640)

IPC Classification